Showing results (181-190 of 679) with videos related to

Sort By:
Pageof 68
Clinical Lymphoma, Myeloma & Leukemia|January 11, 2024
Characterization and Outcomes of Spanish Patients With Relapsed/Refractory Multiple Myeloma Included in the LocoMMotion StudyMaria-Victoria Mateos, Katja Weisel, Joris Diels, et al.
Analytical Chemistry|June 1, 2022
Application of a Cryo-FIB-SEM-μRaman Instrument to Probe the Depth of Vitreous Ice in a Frozen SampleMouad Essani, Jean-Yves Mevellec, Baptiste Charbonnier, et al.
Human Immunology|August 25, 2010
Increased soluble human leukocyte antigen-G levels in peripheral blood from climbers on Mount EverestMichel Bourguignon, Layale Yaghi, Sébastien Flajollet, et al.
ACS Applied Materials & Interfaces|April 26, 2019
Thermomechanical Polymer Binder Reactivity with Positive Active Materials for Li Metal Polymer and Li-Ion Batteries: An XPS and XPS Imaging StudyRabeb Grissa, Alla Abramova, Sacris-Jeru Tambio, et al.
Therapeutic Advances in Hematology|April 8, 2022
An overview of treatment options for patients with relapsed/refractory multiple myeloma and renal impairmentMeletios A Dimopoulos, Joseph Mikhael, Evangelos Terpos, et al.
Future Oncology (London, England)|April 3, 2015
The investigational proteasome inhibitor ixazomib for the treatment of multiple myelomaPaul G Richardson, Philippe Moreau, Jacob P Laubach, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 28, 2016
Higher Early Monocyte and Total Lymphocyte Counts Are Associated with Better Overall Survival after Standard Total Body Irradiation, Cyclophosphamide, and Fludarabine Reduced-Intensity Conditioning Double Umbilical Cord Blood Allogeneic Stem Cell Transplantation in AdultsAmandine Le Bourgeois, Pierre Peterlin, Thierry Guillaume, et al.
Haematologica|June 13, 2012
Updated survival analysis of a randomized phase III study of subcutaneous versus intravenous bortezomib in patients with relapsed multiple myelomaBertrand Arnulf, Halyna Pylypenko, Sebastian Grosicki, et al.
Annals of Hematology|January 8, 2025
Evolution of frontline treatment for multiple myeloma: clinical investigation of quadruplets containing carfilzomib and anti-CD38 monoclonal antibodiesLuciano J Costa, Francesca Gay, Ola Landgren, et al.
Leukemia Research|June 24, 2019
Efficacy and safety results from a phase 1b/2, multicenter, open-label study of oprozomib and dexamethasone in patients with relapsed and/or refractory multiple myelomaParameswaran Hari, Claudia E Paba-Prada, Peter M Voorhees, et al.
Pageof 68